ClinicalMetric / Countries / Netherlands / oncology
← 🇳🇱 Netherlands Trials
🇳🇱 Netherlands Country × Condition

oncology Clinical Trials in Netherlands

Active clinical trials for oncology with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands

Active Trials in Netherlands (3)

NCT07680556
Recruiting

Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

Enrollment
30 pts
Country
🇳🇱 Netherlands
Radboud University Medical Center
View Trial →
NCT06031233 Phase 4
Recruiting

Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie

Enrollment
776 pts
Country
🇳🇱 Netherlands
Isala
View Trial →
NCT04075305
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Enrollment
8,000 pts
Country
🇳🇱 Netherlands
UMC Utrecht
View Trial →

Frequently Asked Questions

How many oncology clinical trials are active in Netherlands?
There are currently 3 active clinical trials for oncology with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a oncology clinical trial in Netherlands?
To join a oncology clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are oncology trials in Netherlands?
Active oncology trials in Netherlands span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Netherlands Trials → Global oncology Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology